- Home
- IVVD vs OIS Comparison
IVVD vs OIS Comparison
Compare IVVD & OIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- OIS
- Stock Information
- Founded
- IVVD 2020
- OIS 1995
- Country
- IVVD United States
- OIS United States
- Employees
- IVVD N/A
- OIS N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- OIS Metal Fabrications
- Sector
- IVVD Health Care
- OIS Industrials
- Exchange
- IVVD Nasdaq
- OIS Nasdaq
- Market Cap
- IVVD 412.6M
- OIS 352.6M
- IPO Year
- IVVD 2021
- OIS 2001
- Fundamental
- Price
- IVVD $2.57
- OIS $6.11
- Analyst Decision
- IVVD Strong Buy
- OIS Hold
- Analyst Count
- IVVD 5
- OIS 1
- Target Price
- IVVD $6.11
- OIS $6.50
- AVG Volume (30 Days)
- IVVD 11.9M
- OIS 668.9K
- Earning Date
- IVVD 11-06-2025
- OIS 10-31-2025
- Dividend Yield
- IVVD N/A
- OIS N/A
- EPS Growth
- IVVD N/A
- OIS N/A
- EPS
- IVVD N/A
- OIS 0.38
- Revenue
- IVVD $50,039,000.00
- OIS $655,119,000.00
- Revenue This Year
- IVVD $102.11
- OIS N/A
- Revenue Next Year
- IVVD $151.51
- OIS $6.35
- P/E Ratio
- IVVD N/A
- OIS $16.05
- Revenue Growth
- IVVD 332.71
- OIS N/A
- 52 Week Low
- IVVD $0.35
- OIS $3.08
- 52 Week High
- IVVD $3.07
- OIS $6.88
- Technical
- Relative Strength Index (RSI)
- IVVD 64.50
- OIS 48.41
- Support Level
- IVVD $2.38
- OIS $6.03
- Resistance Level
- IVVD $2.70
- OIS $6.34
- Average True Range (ATR)
- IVVD 0.25
- OIS 0.27
- MACD
- IVVD 0.07
- OIS -0.05
- Stochastic Oscillator
- IVVD 69.01
- OIS 36.77
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.